PhoreMost’s platform enables the inception of first-in-class drug discovery programmes. PhoreMost is developing an internal asset pipeline in oncology and other diseases of ageing.
Additionally, PhoreMost is engaged in collaborations with Pharma and Biotech across multiple therapeutic areas.